| 0 |
COLOUR VISION TESTS ABNORMAL |
1 |
0.0152 |
| 1 |
KAWASAKI'S DISEASE |
1 |
0.0132 |
| 2 |
ENTEROBACTER TEST POSITIVE |
2 |
0.0081 |
| 3 |
KLEBSIELLA TEST POSITIVE |
2 |
0.0031 |
| 4 |
BRONCHOPLEURAL FISTULA |
1 |
0.0027 |
| 5 |
SLEEP ATTACKS |
1 |
0.0021 |
| 6 |
LUNG INFECTION PSEUDOMONAL |
1 |
0.0018 |
| 7 |
PUPILLARY DISORDER |
1 |
0.0016 |
| 8 |
SOFT TISSUE NECROSIS |
1 |
0.0015 |
| 9 |
NUTRITIONAL CONDITION ABNORMAL |
1 |
0.0014 |
| 10 |
DIET REFUSAL |
1 |
0.0014 |
| 11 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
1 |
0.0013 |
| 12 |
LIGHT CHAIN ANALYSIS INCREASED |
1 |
0.0010 |
| 13 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 14 |
HEPATITIS FULMINANT |
2 |
0.0007 |
| 15 |
SUPERINFECTION |
1 |
0.0007 |
| 16 |
ASTIGMATISM |
1 |
0.0007 |
| 17 |
STRONGYLOIDIASIS |
1 |
0.0006 |
| 18 |
PARAPARESIS |
1 |
0.0006 |
| 19 |
VENOUS OCCLUSION |
1 |
0.0005 |
| 20 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 21 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 22 |
URINARY BLADDER HAEMORRHAGE |
1 |
0.0005 |
| 23 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 24 |
BRAIN ABSCESS |
1 |
0.0004 |
| 25 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 26 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 27 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 28 |
BRONCHOPNEUMONIA |
1 |
0.0003 |
| 29 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 30 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 31 |
ONYCHOMADESIS |
1 |
0.0002 |
| 32 |
BRAIN OEDEMA |
3 |
0.0002 |
| 33 |
MULTIPLE MYELOMA |
1 |
0.0002 |
| 34 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 35 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 36 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 37 |
VISUAL DISTURBANCE |
1 |
0.0002 |
| 38 |
HYPERTHERMIA |
1 |
0.0001 |
| 39 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 40 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 41 |
PATHOGEN RESISTANCE |
1 |
0.0001 |
| 42 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 43 |
LACERATION |
1 |
0.0001 |
| 44 |
SKIN LACERATION |
1 |
0.0001 |
| 45 |
WOUND INFECTION |
1 |
0.0001 |
| 46 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 47 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 48 |
MYDRIASIS |
1 |
0.0001 |
| 49 |
TACHYPNOEA |
1 |
0.0001 |
| 50 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 51 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 52 |
FUNGAL INFECTION |
2 |
0.0001 |
| 53 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 54 |
HEMIPARESIS |
1 |
0.0001 |
| 55 |
DRUG ERUPTION |
1 |
0.0001 |
| 56 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 57 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 58 |
SEPTIC SHOCK |
2 |
0.0000 |
| 59 |
LIVER DISORDER |
2 |
0.0000 |
| 60 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 61 |
HEPATOTOXICITY |
1 |
0.0000 |
| 62 |
SHOCK |
1 |
0.0000 |
| 63 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 64 |
LIVER INJURY |
1 |
0.0000 |
| 65 |
DRUG RESISTANCE |
1 |
0.0000 |
| 66 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 67 |
DIPLOPIA |
1 |
0.0000 |
| 68 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 69 |
HAEMOPTYSIS |
1 |
0.0000 |
| 70 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 71 |
RENAL INJURY |
1 |
0.0000 |
| 72 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 73 |
RASH MACULAR |
1 |
0.0000 |
| 74 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 75 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 76 |
SEPSIS |
3 |
0.0000 |
| 77 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 78 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 79 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 80 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 81 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 82 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 83 |
INFLAMMATION |
1 |
0.0000 |
| 84 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 85 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 86 |
PANCYTOPENIA |
1 |
0.0000 |
| 87 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 88 |
CONVULSION |
1 |
0.0000 |
| 89 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 90 |
PNEUMONIA |
5 |
0.0000 |
| 91 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 92 |
RENAL FAILURE |
2 |
0.0000 |
| 93 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 94 |
INFECTION |
2 |
0.0000 |
| 95 |
CARDIAC FAILURE |
1 |
0.0000 |
| 96 |
TACHYCARDIA |
1 |
0.0000 |
| 97 |
HAEMORRHAGE |
1 |
0.0000 |
| 98 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 99 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 100 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 101 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 102 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 103 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 104 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 105 |
HYPOTENSION |
1 |
0.0000 |
| 106 |
SOMNOLENCE |
1 |
0.0000 |
| 107 |
ERYTHEMA |
1 |
0.0000 |
| 108 |
DECREASED APPETITE |
1 |
0.0000 |
| 109 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 110 |
WEIGHT DECREASED |
1 |
0.0000 |
| 111 |
DYSPNOEA |
2 |
0.0000 |
| 112 |
DEATH |
3 |
0.0000 |
| 113 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 114 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 115 |
FALL |
1 |
0.0000 |
| 116 |
PYREXIA |
1 |
0.0000 |
| 117 |
RASH |
1 |
0.0000 |
| 118 |
VOMITING |
1 |
0.0000 |
| 119 |
DIZZINESS |
1 |
0.0000 |
| 120 |
DIARRHOEA |
1 |
0.0000 |
| 121 |
NAUSEA |
1 |
0.0000 |
| 122 |
OFF LABEL USE |
1 |
0.0000 |